Interferon vs glatiramer acetate
Number of participants with confirmed progression Risk ratio (M‐H, random, 95% CI) · patients with relapsing‐remitting multiple sclerosis
Interferons showed no clear difference in number of participants with confirmed progression Risk ratio (M‐H,… compared with glatiramer acetate (moderate certainty).
1 finding from 1 review
- Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis 2016 · Cochrane Headline outcomes onlyRR 1.11 [0.91, 1.35]3 studies · 2169 participantsModerate